According to a 2024 KFF Health Tracking Poll, 1 in 8 US adults has now taken a GLP-1 medication
Think of it as the supply chain
Celsius and Starbucks Triple Shot Energy are the functional association standouts in the segment
Liraglutide was the first GLP-1 receptor analogue approved for the management of obesity, thus starting the new era of gastrointestinal peptide agonist pharmacotherapy for the treatment of both diabetes and obesity
GLP-1 Agonists For Obesity Weight loss medications are approved for adults with obesity (BMI of 30 kg/m2 or more) or overweight (BMI of 27 kg/m2 or more) with a weight-related comorbidity, including high blood pressure, type 2 diabetes, or high cholesterol
Thus, in metabolically healthy individuals, the fertility impact appears minimal